The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Diagnosis, pathogenesis and treatment of attention deficiency syndrome
Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(6): 22‑29
Views: 9373
Downloaded: 203
To cite this article:
Zykov VP, Komarova IB. Diagnosis, pathogenesis and treatment of attention deficiency syndrome. S.S. Korsakov Journal of Neurology and Psychiatry.
2023;123(6):22‑29. (In Russ.)
https://doi.org/10.17116/jnevro202312306122
Attention deficit hyperactivity disorder is the dominant form of cognitive and behavioral dysfunctions in childhood, the disease has a chronic course and manifests in adolescents and adults in 50—80% of cases. An adequate diagnosis is the testing of parents and teachers using the Conners questionnaire in two stages, the second is mandatory after 6 months to confirm the persistence of symptoms over time. The pathogenesis is based on violations of mediation of dopamine and norepinephrine in the fronto-striate-thalamic system, responsible for the function of constant attention, caused by molecular genetic mechanisms. Atomoxetine (Cognitera) in combination with pedagogical and psychological methods of correction seems to be an adequate drug for many months of use, taking into account international and Russian experience of use.
Authors:
Received:
29.03.2023
Accepted:
01.06.2023
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.